MANH vs. NTNX, APPF, RP, SMAR, QTWO, WDAY, ADSK, FICO, MSTR, and ANSS
Should you be buying Manhattan Associates stock or one of its competitors? The main competitors of Manhattan Associates include Nutanix (NTNX), AppFolio (APPF), RealPage (RP), Smartsheet (SMAR), Q2 (QTWO), Workday (WDAY), Autodesk (ADSK), Fair Isaac (FICO), MicroStrategy (MSTR), and ANSYS (ANSS). These companies are all part of the "computer and technology" sector.
Manhattan Associates (NASDAQ:MANH) and Nutanix (NASDAQ:NTNX) are both large-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, community ranking, valuation and earnings.
In the previous week, Manhattan Associates had 38 more articles in the media than Nutanix. MarketBeat recorded 47 mentions for Manhattan Associates and 9 mentions for Nutanix. Nutanix's average media sentiment score of 0.93 beat Manhattan Associates' score of 0.43 indicating that Nutanix is being referred to more favorably in the news media.
Manhattan Associates has a beta of 1.5, suggesting that its stock price is 50% more volatile than the S&P 500. Comparatively, Nutanix has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500.
98.5% of Manhattan Associates shares are owned by institutional investors. Comparatively, 85.3% of Nutanix shares are owned by institutional investors. 0.7% of Manhattan Associates shares are owned by insiders. Comparatively, 0.5% of Nutanix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Manhattan Associates has a net margin of 20.54% compared to Nutanix's net margin of -0.57%. Manhattan Associates' return on equity of 84.54% beat Nutanix's return on equity.
Manhattan Associates has higher earnings, but lower revenue than Nutanix. Nutanix is trading at a lower price-to-earnings ratio than Manhattan Associates, indicating that it is currently the more affordable of the two stocks.
Manhattan Associates presently has a consensus target price of $257.43, indicating a potential downside of 0.40%. Nutanix has a consensus target price of $72.00, indicating a potential upside of 45.68%. Given Nutanix's stronger consensus rating and higher possible upside, analysts clearly believe Nutanix is more favorable than Manhattan Associates.
Nutanix received 159 more outperform votes than Manhattan Associates when rated by MarketBeat users. Likewise, 69.57% of users gave Nutanix an outperform vote while only 63.01% of users gave Manhattan Associates an outperform vote.
Summary
Manhattan Associates beats Nutanix on 11 of the 18 factors compared between the two stocks.
Get Manhattan Associates News Delivered to You Automatically
Sign up to receive the latest news and ratings for MANH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MANH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Manhattan Associates Competitors List
Related Companies and Tools
